Display options
Share it on

Hippokratia. 2009 Apr;13(2):122-4.

Severe migratory Angioedema due to ACE inhibitors use.

Hippokratia

G Peltekis, D Palaskas, M Samanidou, A Fragakis, K Alexopoulos, A Kotsani, I Vogiatzis, E Kyrmizakis

Affiliations

  1. ENT Department of Veroia General Hospital, Veroia, Greece.

PMID: 19561786 PMCID: PMC2683457

Abstract

Angioedema due to use of angiotensin-converting enzyme inhibitors (ACEIs) is a rare side-effect but is seen more often because of the increase in the use of these drugs due to their effectiveness and good tolerance in the treatment of hypertension and congestive heart failure. Other types of angioedema, which should be included in the differential diagnosis, are the hereditary type, which results from deficiency of C1 esterase inhibitor and the allergic angioedema. Angioedema is a potentially life-threatening condition when it is located to the mucosal and submucosal layers of the upper airway. Some times an angioedema case can be very severe, resistant to the usual treatment and even rarely fatal. The last eight months, six patients with angioedema due to ACEIs (5 cases) or angiotensin II receptor blockers (1 case), were examined and hospitalized at our department. We describe the case of a 65 year old woman with severe migratory angioedema of the tongue, the floor of the mouth and the oropharynx, which was rather resistant to the usual treatment.

Keywords: ACE inhibitors; angioedema

References

  1. J Laryngol Otol. 1994 Aug;108(8):696-8 - PubMed
  2. Am J Otolaryngol. 1998 Nov-Dec;19(6):394-6 - PubMed
  3. Intensive Care Med. 1997 Jul;23(7):793-6 - PubMed
  4. Ann Emerg Med. 1984 Jun;13(6):489-90 - PubMed
  5. Eur Arch Otorhinolaryngol. 2002 Sep;259(8):419-21 - PubMed
  6. Ann Pharmacother. 1996 Jan;30(1):55-61 - PubMed
  7. J Otolaryngol. 1985 Feb;14(1):14-6 - PubMed
  8. Ann Intern Med. 1990 Feb 15;112(4):312-3 - PubMed
  9. Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1416-9 - PubMed
  10. Laryngoscope. 2001 Oct;111(10):1729-31 - PubMed
  11. J Clin Pharmacol. 1996 Jan;36(1):3-12 - PubMed

Publication Types